Skip to content

Postoperative Pain in Laparoscopic Radical Prostatectomy Surgery With Tranexamic Acid: Analgesia? Hiperalgesia?

Evaluation of Postoperative Pain in Laparoscopic Radical Prostatectomy Surgery With Tranexamic Acid: Analgesia? Hiperalgesia?

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06040853
Enrollment
90
Registered
2023-09-18
Start date
2023-09-30
Completion date
2024-03-30
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pharmacological Action

Brief summary

Prostate cancer is the most diagnosed cancer among men today. Radical prostatectomy is a surgery that significantly reduces disease-related mortality. The laparoscopic technique, on the other hand, is preferred because it shortens the hospital stay, faster recovery and less postoperative pain.In this study, it was planned to investigate the analgesic or hyperalgesic effects of tranexamic acid, which is widely used in the management of bleeding in trauma, orthopedic, genitourinary and gynecological surgeries. Routine noninvasive monitoring (ECG, Spo2, NIBP) will be performed when participatient are taken to the operating table without premedication. After midazolam is administered, intubation will be performed by administering 1mg/kg lidocaine, 3mg/kg propofol, 2mcg/kg fentanyl, 0.6mg/kg rocuronium. Anesthesia will be maintained with desflurane with a MAC of 1. A 0.1-0.5 mcg/kg/min remifentanil infusion will be administered by targeting 40-60 values with BIS monitoring. After intubation, 15mg/kg tranexamic acid will be given 10 minutes before the incision, and 100 mg/h infusion will be administered until the skin is closed. The control group will be given 100 ml of saline.1mg/kg tramadol and 1gr parol will be administered 30 minutes before the end of the operation. The primary objectives of the study were to learn the VAS (Visual analog scale) score at 0.6,12, 24,48,72 hours, time to first analgesic requirement, and analgesic requirement within 24 hours. Secondary purposes are to determine the amount of antiemetic used, at the beginning of the operation, Hg at the first hour and postoperative 6 hours, complications and side effects (such as DVT, pulmonary embolism).

Detailed description

Prostate cancer is the most diagnosed cancer among men today. Radical prostatectomy is a surgery that significantly reduces disease-related mortality. The laparoscopic technique, on the other hand, is preferred because it shortens the hospital stay, faster recovery and less postoperative pain.In this study, it was planned to investigate the analgesic or hyperalgesic effects of tranexamic acid, which is widely used in the management of bleeding in trauma, orthopedic, genitourinary and gynecological surgeries

Interventions

DRUGTranexamic acid intravenous administration

Participants will be given 15mg/kg tranexamic acid before the incision in ten minutes, 100 mg/h will continue until the end of the surgery.

DRUGSaline

Participant was given intravenous 100 ml saline

Sponsors

Dr. Lutfi Kirdar Kartal Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Elective laparoscopic radical prostatectomy will be performed; Surgeon with more than 10 years of laparoscopic prostatectomy experience * Participant BMI(weight/height2)(kg/m2)\<35 * ASA2-3 * Participant Age\>18 * Participant Age\<75

Exclusion criteria

* Coagulation disorder, * Chronic renal failure, * Patients allergic to tranexamic acid, * Participant Age\<18 * Participant Age\>75, * Participant BMI(weight/height2)(kg/m2)\>35, * Surgeon with less than 10 years of laparoscopic prostatectomy experience, * Patients who had a cerebral, coronary and thromboembolic event within 6 months before the operation

Design outcomes

Primary

MeasureTime frameDescription
Visual analog scale, time of first analgesic requirement, used within 24 hours amount of analgesic,Change from baseline at 0., 6., 12., 24., 48., 72. hours VAS scoreInvestigators will evaluate VAS score, time of first analgesic requirement, used within 24 hours amount of analgesic,

Secondary

MeasureTime frameDescription
side effect, 0., 1., 6. hours hemogram value, amount of antiemetic usedChange from baseline at 0., 1., 6. hoursInvestigators will evaluate demographic characteristics \[years, female/male, weight(kg),height(meter), BMI (kg/m2 )\], side effect, 0,1,6 st hour hemogram value, amount of antiemetic used.

Contacts

Primary Contactgülten arslan, Assoc prof
gulten.arslan@yahoo.com.tr+905323620366

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026